• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Arno Therapeutics Inc

+ Add to Watchlist


0.5801 USD 0.0401 7.43%

As of 17:20:02 ET on 12/26/2014.

Snapshot for Arno Therapeutics Inc (ARNI)

Open: 0.6100 Day's Range: 0.5300 - 0.6350 Volume: 34,770
Previous Close: 0.5400 52wk Range: 0.4300 - 3.0000 1-Yr Rtn: -77.77%

Stock Chart for ARNI

No chart data available.
  • ARNI:US 0.5801
  • 1D
  • 1M
  • 1Y
Interactive ARNI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARNI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -1.3800
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 11.84
Shares Outstanding (M) 20.41
30 Day Average Volume 14,452
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARNI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARNI

Arno Therapeutics, Inc. is a development-stage company. The Company acquires, develops and commercializes products for the treatment of cancer. Arno seeks to acquire rights to novel, preclinical or early stage clinical oncology product candidates, primarily from academic and research institutions.

Alexander A Zukiwski "Alex"CEO/Chief Medical OfficerLawrence A Kenyon "Larry"CFO/COO
Stefan ProniukVP:Product DevelopmentDavid M TanenSecretary/Co-Founder
More Company Profile & Key Executives for ARNI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil